XML 23 R11.htm IDEA: XBRL DOCUMENT v3.25.3
Revenues
 9 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenues
Note 3. Revenues
Revenues are recognized under guidance within ASC 606, Revenue from Contracts with Customers. The following table presents our disaggregated revenue for the periods presented (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
JAKAFI revenues, net$791,071 $741,181 $2,264,271 $2,018,993 
OPZELURA revenues, net187,968 139,272 471,172 346,691 
ICLUSIG revenues, net37,582 29,745 99,855 86,950 
PEMAZYRE revenues, net22,741 20,661 63,373 58,606 
MINJUVI/MONJUVI revenues, net41,990 31,439 102,672 86,429 
NIKTIMVO revenues, net45,830 — 95,597 — 
ZYNYZ revenues, net22,674 694 34,604 1,812 
Total product revenues, net1,149,856 962,992 3,131,544 2,599,481 
JAKAVI product royalty revenues125,645 115,741 327,504 304,653 
OLUMIANT product royalty revenues37,111 34,796 101,393 97,087 
TABRECTA product royalty revenues6,513 5,928 19,558 16,460 
Other product royalty revenues1,855 414 4,408 1,838 
Total product royalty revenues171,124 156,879 452,863 420,038 
Milestone and contract revenues45,000 18,000 50,000 43,000 
Total revenues$1,365,980 $1,137,871 $3,634,407 $3,062,519 
For further information on the MINJUVI/MONJUVI revenues, refer to Note 6, and for further information on our revenue-generating contracts, refer to Note 8.